Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Athos Therapeutics Inc

Clinical trials sponsored by Athos Therapeutics Inc, explained in plain language.

Not yet recruiting 1

New hope for ulcerative colitis patients who Haven't responded to biologics

Disease control Not yet recruiting

This study tests a new drug called ATH-063 in people with moderate to severe ulcerative colitis who have not improved with other advanced treatments. The goal is to see if the drug can reduce symptoms like diarrhea and bleeding and help the gut heal. About 120 adults will receive…

Phase: PHASE2 • Sponsor: Athos Therapeutics Inc • Aim: Disease control

Last updated May 18, 2026 12:10 UTC